<i>PMEPA1</i> Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer

by Shashwat Sharad, Albert Dobi, Shiv Srivastava, Alagarsamy Srinivasan, Hua Li
Published 2020-08-01

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing

by Kar Muthumani, Ziyang Xu, Moonsup Jeong, Joel N. Maslow, Vaniambadi S. Kalyanaraman, Alagarsamy Srinivasan
Published 2021-07-01

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing

by Sundarasamy Mahalingam, John Peter, Ziyang Xu, Devivasha Bordoloi, Michelle Ho, Vaniambadi S. Kalyanaraman, Alagarsamy Srinivasan, Kar Muthumani
Published 2021-04-01

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

by Michael A. Kiebish, Jennifer Cullen, Prachi Mishra, Amina Ali, Eric Milliman, Leonardo O. Rodrigues, Emily Y. Chen, Vladimir Tolstikov, Lixia Zhang, Kiki Panagopoulos, Punit Shah, Yongmei Chen, Gyorgy Petrovics, Inger L. Rosner, Isabell A. Sesterhenn, David G. McLeod, Elder Granger, Rangaprasad Sarangarajan, Viatcheslav Akmaev, Alagarsamy Srinivasan, Shiv Srivastava, Niven R. Narain, Albert Dobi
Published 2020-01-01

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia

by Michael A. Kiebish, Poornima Tekumalla, Shobha Ravipaty, Albert Dobi, Shiv Srivastava, Wenfang Wu, Saurabh Patil, Tracey Friss, Allison Klotz, Alagarsamy Srinivasan, Jennifer Cullen, Inger L. Rosner, Amina Ali, Sandra Laszlo, Michele Petrovic, Neil Fleshner, Jeonifer Garren, Greg Miller, Nischal Mahaveer Chand, Leonardo O. Rodrigues, Elder Granger, Mark D. Kellogg, Shen Luan, Eleftherios Diamandis, Viatcheslav R. Akmaev, Rangaprasad Sarangarajan, Chas Bountra, Stephen J. Freedland, David G. McLeod, Niven R. Narain
Published 2021-07-01